Keenova Therapeutics plc

CIK 1567892 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Keenova Therapeutics plc.

Recent SEC filings

FiledFormAccession number
Aug 11, 202610-Q0001628280-26-055614
Aug 11, 20268-K0001628280-26-055477
Aug 3, 20268-K0001104659-26-089655
Jul 23, 202640001104659-26-086328
Jul 23, 202640001104659-26-086326
Jul 23, 202640001104659-26-086329
Jul 17, 202640001104659-26-084780
Jul 17, 202640001104659-26-084775
Jul 17, 202640001104659-26-084777
Jul 17, 202640001104659-26-084781
Jul 17, 202640001104659-26-084778
Jul 17, 202640001104659-26-084779
Jul 17, 202640001104659-26-084776
Jul 17, 202640001104659-26-084774
Jul 17, 20264/A0001104659-26-084773
Jul 8, 20268-K0001104659-26-081562
Jun 15, 20268-K0001104659-26-073787
Jun 4, 202640001104659-26-070520
Jun 4, 202640001104659-26-070526
Jun 4, 202640001104659-26-070524
Jun 4, 202640001104659-26-070516
Jun 4, 202640001104659-26-070519
Jun 4, 202640001104659-26-070521
Jun 4, 202640001104659-26-070525
Jun 4, 202640001104659-26-070527